Ketbi Latifa Baynouna Al, Shuaib Fatima Mohsen, Al Nuaimi Jawaher Mohammed, Alawi Noura Saeed Al, Nagelkerke Nico, Zarooni Amal Abdul Rahim Al, AlShamsi Noura, Fahmawee Toqa, AlHashaikeh Basil, AlKetbi Rudina, AlDobaee Muna, AlAhbabi Nayla, AlAzeezi AlYazia, AlKalbani Sanaa, Saeed Ekram, AlMansoori Mohammed, Humaid Ahmed, Aleissaee Hamda, AlKetbi Fatima, Al Meqbaali Fatima Yousef
Department of Family Medicine, Abu Dhabi Health Services, Abu Dhabi, United Arab Emirates.
College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, Abu Dhabi, United Arab Emirates.
Arch Public Health. 2025 Mar 21;83(1):73. doi: 10.1186/s13690-025-01564-w.
Assessing the burden of mental health disorders is critical for planning the best healthcare services and responding to community needs. This study aimed to assess the mental health burden in Abu Dhabi, United Arab Emirates and its important determinants.
This retrospective cohort study included participants from a national cardiovascular screening program (Weqaya) in Abu Dhabi, United Arab Emirates, from 2010 to 2013. The data were collected through electronic medical records (EMRs). A total of 8699 subjects were included, with an average follow-up period of 9.2 years. Participants' EMRs were reviewed in 2023 by physicians and nurses through electronic medical records for a diagnosis of mental health disorders or any psychiatric medication prescribed.
The prevalence of mental health disorders among this cohort was 3.8%. Compared with males, females had a greater prevalence of mental illnesses. The highest prevalence of mental health disorders was among younger age groups (< 30 years old). Mood disorders had the highest prevalence. A history of psychiatric illnesses was significantly associated with the following baseline characteristics at screening: prediabetes mellitus status, smoking status, coronary heart disease status, dyslipidemia at screening, high-density lipoprotein (HDL) level and female sex. With regard to associated outcomes during the follow-up years, psychiatric illness was significantly associated with smoking at any time, chronic kidney disease, metabolic dysfunction-associated fatty liver disease (MUFLD), and diabetes mellitus. Moreover, logistic regression revealed that death, as a dependent variable, was associated with an increased risk of mortality. Such an increase in mortality compared with that in the general population was not found among patients with psychiatric illnesses who were using statins.
The prevalence of diagnosed and treated mental health disorders was not as high as that in other regions of the world, but when adjusted for age, it was close to the average worldwide prevalence. The discrepancy between questionnaire-based prevalence and our prevalence highlights the mental health burden that necessitates further studies. Furthermore, more studies are needed to estimate the prevalence in the total population of the UAE. The higher risk of mortality found in this study indicates that mental illness is either a risk factor for death or an outcome of higher-risk patients, which also needs to be confirmed by future studies.
评估心理健康障碍的负担对于规划最佳医疗服务和满足社区需求至关重要。本研究旨在评估阿拉伯联合酋长国阿布扎比的心理健康负担及其重要决定因素。
这项回顾性队列研究纳入了2010年至2013年期间参与阿拉伯联合酋长国阿布扎比一项全国心血管筛查项目(Weqaya)的参与者。数据通过电子病历(EMR)收集。共纳入8699名受试者,平均随访期为9.2年。2023年,医生和护士通过电子病历对参与者的电子病历进行审查,以诊断心理健康障碍或任何开具的精神科药物。
该队列中心理健康障碍的患病率为3.8%。与男性相比,女性精神疾病的患病率更高。心理健康障碍患病率最高的是年龄较小的群体(<30岁)。情绪障碍的患病率最高。在筛查时,精神疾病史与以下基线特征显著相关:糖尿病前期状态、吸烟状态、冠心病状态、筛查时的血脂异常、高密度脂蛋白(HDL)水平和女性性别。关于随访期间的相关结局,精神疾病与任何时候的吸烟、慢性肾病、代谢功能障碍相关脂肪性肝病(MUFLD)和糖尿病显著相关。此外,逻辑回归显示,作为因变量的死亡与死亡率增加相关。在使用他汀类药物的精神疾病患者中,未发现与普通人群相比死亡率有这种增加。
已诊断和治疗的心理健康障碍的患病率不如世界其他地区高,但经年龄调整后,接近全球平均患病率。基于问卷的患病率与我们的患病率之间的差异凸显了心理健康负担,这需要进一步研究。此外,需要更多研究来估计阿联酋总人口中的患病率。本研究中发现的较高死亡风险表明,精神疾病要么是死亡的危险因素,要么是高危患者的结局,这也需要未来的研究来证实。